TrialMedical oncology (Northwood, London, England)2014

Assessment of efficacy, safety and quality of life of 110 patients treated with sunitinib as first-line therapy for metastatic renal cell carcinoma: experience in real-world clinical practice in Japan.

Hideaki Miyake et al.PubMed ↗Publisher ↗

No numbers read from the abstract.